查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2146819

人工智慧醫學影像分析軟體市場（肺部疾病）：全球市場預測（2026-2032年）

AI Medical Imaging Software for Lung Diseases Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，用於肺部疾病的 AI 醫學影像軟體市場將成長至 133,698 億美元，複合年成長率為 7.92%。

主要市場統計數據
基準年 2025 7.8403億美元
預計年份：2026年 8.4127億美元
預測年份 2032 1,336,980,000 美元
複合年成長率 (%) 7.92%

用於肺部疾病的AI驅動型醫學影像軟體：概述

用於肺部疾病的AI驅動型醫學影像軟體，將機器學習、電腦視覺和臨床決策支援技術應用於胸部X光片、電腦斷層掃描（CT）和磁振造影（MRI）等影像技術。其主要應用包括輔助檢測、影像分流、疾病模式量化、工作流程優先排序和時間序列監測。部署資格取決於臨床有效性、互通性、法規核准、網路安全、保險報銷以及能否安全整合到放射科和呼吸科的臨床流程中。

臨床工作流程正從單純的檢測轉向綜合決策支援。

目前的趨勢正從孤立的影像分類轉向支援整個診斷工作流程的工具，包括方案最佳化、自動測量、結構化報告、急診病例優先排序以及與先前檢測結果的比較。這種轉變進一步強調了可解釋性、跨掃描儀和目標人群的校準以及人工監督的重要性。有效實施需要將軟體整合到現有的影像歸檔和通訊系統 (PACS)、電子健康記錄(EHR) 和多學科診療流程中，而不是添加一個單獨的獨立介面。

人工智慧在提升處理能力的同時，也提高了管治要求。

人工智慧可以幫助臨床醫生管理海量影像數據，識別細微的觀察，減少重複的測量工作，並規範影像解讀支援。當資料管理得當且工作流程清晰明確時，其累積效應最為顯著。同時，其性能會因目標族群特徵、成像方案、影像品質和疾病盛行率的不同而有所差異。因此，管理者需要持續監測績效波動，透明地記錄其預期用途，並制定明確的規則來評估偏差、保護隱私，以及明確最終臨床決策的責任歸屬。

每個地區的具體情況將決定實施的速度和形式。

北美受益於成熟的數位基礎設施、積極的臨床檢驗和完善的監管流程，而拉丁美洲則受到影像能力、網路連接和專家知識獲取方面差異的影響。歐洲強調在不同國家環境下，隱私、適用性評估、互通性和醫療保健系統的證據。中東在投資先進的醫療保健基礎設施和集中式服務方面取得了進展，而非洲則在設備可用性、網路連接、人力資源能力和數據代表性方面面臨顯著差異。亞太地區擁有先進的創新生態系統，但同時在醫療保健的可近性、監管成熟度和都市區服務分佈方面也存在顯著差異。

經濟和安全聯盟決定了採購和互通性的優先事項。

在東協市場，跨不同醫療體系的擴充性部署和跨境互通性通常是優先考慮的因素。金磚國家成員國在公共部門能力、國家技術優先事項和監管方式方面存在差異。歐盟高度重視隱私、安全、相容性和互通性資料環境。七國集團（G7）醫療體系通常擁有強大的臨床基礎設施，但在證據、人力資源和整合方面仍面臨挑戰。海灣合作理事會（GCC）國家通常支持集中式數位醫療計畫和專科醫療服務的擴展。北約成員國也高度關注網路韌性、業務連續性、安全基礎設施和供應鏈風險。

每個國家的實際情況都為實施工作帶來了獨特的機會和限制。

澳洲和加拿大在應對人口分散和確保廣大領土上公平獲取醫療服務方面面臨挑戰。巴西、墨西哥、印度和南非在基礎設施、專家資源和公私合營模式方面存在顯著差異。中國、日本和韓國擁有先進的技術能力，並具備獨特的監管、採購和資料管治環境。法國、德國、義大利、西班牙和英國的醫療體系成熟，臨床證據、工作流程整合、隱私和報銷是部署過程中的核心考量。俄羅斯的部署環境受其國內基礎設施、監管環境和專業技術取得途徑的影響。在美國，醫療服務規模、監管合規性、互通性和問責制仍然是部署過程中的關鍵考慮因素。

優先考慮檢驗的用例、互通性和持續的臨床監測。

產業領導者應從明確界定的臨床問題入手，例如急診病例分診和可重複病變的量化，並基於具有臨床意義的指標（而不僅僅是技術準確性）來評估結果。他們還應要求進行具有代表性的現場檢驗、亞組測試、前瞻性工作流程評估以及對局限性的透明記錄。採購應涵蓋互通性標準、網路安全措施、可審計性、資料保存規則、模型更新管治以及服務水準預期。成功的計畫還會投資於臨床醫生培訓、升級流程、實施後監測以及連接放射科醫生、肺科醫生、放射技師、IT團隊和患者的結構化回饋機制。

調查方法：基於證據的臨床、技術和系統因素評估。

本執行摘要對目前用於肺部疾病的人工智慧醫學影像軟體進行了結構化的定性評估。評估考慮了同儕審查的臨床證據、監管和安全原則、醫療數位化現狀、影像工作流程要求、互通性實踐、隱私和網路安全預期，以及國家和地區醫療保健系統的特點。評估結果按應用、部署障礙、實施要求和管治考量等主題進行整合。本摘要不包含任何市場估算、預測、市場佔有率、預估或公司特定聲明。

負責任的整合決定著長期價值。

如果人工智慧驅動的醫學影像軟體經過臨床檢驗、適應當地情況、互通性，並作為一項持續監測的醫療保健技術進行管理，則可以管治肺部疾病的治療過程。最佳效果來自於能夠補充而非取代專家判斷的實施方案，它將技術能力與在及時性、一致性、可及性和患者安全方面可衡量的改進相結合。儘管由於地區和國家差異，針對具體情況的實施模式至關重要，但可靠的證據和透明的課責仍然是永續應用的基礎。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：肺部疾病人工智慧醫學影像分析軟體市場：按組件分類

  • 服務
    • 託管服務
    • 專業服務
  • 軟體
    • 整合平台
    • 獨立軟體

第8章：肺部疾病人工智慧醫學影像分析軟體市場：以影像方式分類

  • 電腦斷層掃描（CT）
  • 磁振造影
  • 正子斷層掃描（PET）
  • X光

第9章：肺部疾病人工智慧醫學影像分析軟體市場：依疾病類型分類

  • 慢性阻塞性肺病
  • 肺癌
  • 肺炎
  • 結核

第10章：人工智慧醫學影像分析軟體市場－肺部疾病應用領域

  • 診斷
  • 監測
  • 篩檢
  • 手術支援

第11章：肺部疾病人工智慧醫學影像分析軟體市場：按最終用戶分類

  • 門診治療
  • 診斷中心
  • 醫院
  • 研究機構

第12章：肺部疾病人工智慧醫學影像分析軟體市場：依部署方式分類

  • 基於雲端的
    • 混合雲端
    • 私有雲端
    • 公共雲端
  • 現場
    • 邊緣伺服器
    • 私人資料中心

第13章：肺部疾病人工智慧醫學影像分析軟體市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：肺部疾病人工智慧醫學影像分析軟體市場：按類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：人工智慧醫學影像分析軟體在肺部疾病領域的市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Aidoc Ltd.
  • Annalise.ai Pty Ltd
  • Arterys, Inc.
  • GE HealthCare Inc.
  • Infervision Technology Co., Ltd.
  • Koninklijke Philips NV
  • Lunit Inc.
  • Optellum Ltd.
  • Oxipit Labs UAB
  • Qure.ai Technologies Pvt. Ltd.
  • Riverain Technologies, LLC
  • Siemens Healthineers AG
  • Thirona NV
  • VIDA Diagnostics, Inc.
  • Zebra Medical Vision Ltd.

第18章 主要專家

Product Code: MRR-3D150775E415

The AI Medical Imaging Software for Lung Diseases Market is projected to grow by USD 1,336.98 million at a CAGR of 7.92% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 784.03 million
Estimated Year [2026] USD 841.27 million
Forecast Year [2032] USD 1,336.98 million
CAGR (%) 7.92%

AI Medical Imaging Software for Lung Diseases: Executive Overview

AI medical imaging software for lung diseases applies machine learning, computer vision, and clinical decision-support techniques to modalities such as chest radiography, computed tomography, and magnetic resonance imaging. Its principal uses include detection support, image triage, quantification of disease patterns, workflow prioritization, and longitudinal monitoring. Adoption is shaped by clinical validation, interoperability, regulatory clearance, cybersecurity, reimbursement, and the ability to integrate safely into radiology and pulmonary-care pathways.

Clinical Workflows Are Shifting from Detection to Integrated Decision Support

The landscape is moving beyond isolated image classification toward tools that support the full diagnostic workflow, including protocol optimization, automated measurements, structured reporting, urgent-case prioritization, and comparison with prior examinations. This shift increases the importance of explainability, calibration across scanners and populations, and human oversight. Effective deployment depends on embedding software into existing picture archiving and communication systems, electronic health records, and multidisciplinary care processes rather than adding another disconnected interface.

Artificial Intelligence Is Increasing Throughput While Raising Governance Requirements

Artificial intelligence can help clinicians manage high imaging volumes, identify subtle findings, reduce repetitive measurement work, and standardize interpretation support. Its cumulative effect is strongest where data are well curated and workflows are clearly defined. At the same time, performance can vary with population characteristics, acquisition protocols, image quality, and disease prevalence. Leaders therefore need continuous monitoring for drift, transparent documentation of intended use, bias assessment, privacy safeguards, and clear rules assigning responsibility for final clinical decisions.

Regional Conditions Determine the Pace and Form of Adoption

North America benefits from mature digital infrastructure, active clinical validation, and established regulatory pathways, while Latin America is influenced by uneven access to imaging capacity, connectivity, and specialist expertise. Europe emphasizes privacy, conformity assessment, interoperability, and health-system evidence across diverse national settings. The Middle East is investing in advanced healthcare infrastructure and centralized services, whereas Africa faces significant differences in equipment availability, connectivity, workforce capacity, and data representativeness. Asia-Pacific combines advanced innovation ecosystems with substantial variation in healthcare access, regulatory maturity, and urban-rural service distribution.

Economic and Security Alliances Shape Procurement and Interoperability Priorities

ASEAN markets commonly prioritize scalable deployment across diverse health systems and cross-border interoperability. BRICS members reflect varied public-sector capacity, domestic technology priorities, and regulatory approaches. The European Union places strong emphasis on privacy, safety, conformity, and interoperable data environments. G7 systems generally have extensive clinical infrastructure but face evidence, workforce, and integration requirements. GCC countries often support centralized digital-health programs and specialist-care expansion. NATO members also give heightened attention to cyber resilience, continuity of operations, secure infrastructure, and supply-chain risk.

Country Contexts Create Distinct Deployment Opportunities and Constraints

Australia and Canada must address dispersed populations and equitable access across large territories. Brazil, Mexico, India, and South Africa face substantial variation in infrastructure, specialist availability, and public-private delivery models. China, Japan, and South Korea combine advanced technical capabilities with distinctive regulatory, procurement, and data-governance environments. France, Germany, Italy, Spain, and the United Kingdom operate within mature healthcare systems where clinical evidence, workflow integration, privacy, and reimbursement are central adoption considerations. Russia's deployment environment is shaped by domestic infrastructure, regulatory conditions, and access to specialized technology. Across the United States, scale of care delivery, regulatory compliance, interoperability, and liability management remain major implementation considerations.

Prioritize Validated Use Cases, Interoperability, and Continuous Clinical Oversight

Industry leaders should begin with clearly defined clinical problems, such as urgent-case triage or reproducible lesion quantification, and evaluate outcomes against clinically meaningful measures rather than technical accuracy alone. They should require representative local validation, subgroup testing, prospective workflow assessment, and transparent documentation of limitations. Procurement should include interoperability standards, cybersecurity controls, auditability, data-retention rules, model-update governance, and service-level expectations. Successful programs also invest in clinician training, escalation procedures, post-deployment monitoring, and structured feedback loops linking radiologists, pulmonologists, technologists, information-technology teams, and patients.

Methodology: Evidence-Based Assessment of Clinical, Technical, and System Factors

This executive summary uses a structured qualitative assessment of the AI medical imaging software landscape for lung diseases. The assessment considers peer-reviewed clinical evidence, regulatory and safety principles, healthcare digitization conditions, imaging workflow requirements, interoperability practices, privacy and cybersecurity expectations, and country- and region-level health-system characteristics. Findings are synthesized thematically across applications, adoption barriers, implementation requirements, and governance considerations. No market estimates, market shares, forecasts, or company-specific claims are used.

Responsible Integration Will Define Long-Term Value

AI medical imaging software can strengthen lung-disease pathways when it is clinically validated, locally appropriate, interoperable, and governed as a continuously monitored medical technology. The strongest results will come from implementations that augment-not replace-professional judgment and that connect technical performance with measurable improvements in timeliness, consistency, access, and patient safety. Regional and country differences make adaptable deployment models essential, while robust evidence and transparent accountability remain the foundation for sustainable use.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. AI Medical Imaging Software for Lung Diseases Market, by Component

  • 7.1. Introduction
  • 7.2. Services
    • 7.2.1. Managed Services
    • 7.2.2. Professional Services
  • 7.3. Software
    • 7.3.1. Integrated Platform
    • 7.3.2. Standalone Software

8. AI Medical Imaging Software for Lung Diseases Market, by Modality

  • 8.1. Introduction
  • 8.2. Computed Tomography
  • 8.3. Magnetic Resonance Imaging
  • 8.4. Positron Emission Tomography
  • 8.5. X Ray

9. AI Medical Imaging Software for Lung Diseases Market, by Disease Type

  • 9.1. Introduction
  • 9.2. Chronic Obstructive Pulmonary Disease
  • 9.3. Lung Cancer
  • 9.4. Pneumonia
  • 9.5. Tuberculosis

10. AI Medical Imaging Software for Lung Diseases Market, by Application

  • 10.1. Introduction
  • 10.2. Diagnostics
  • 10.3. Monitoring
  • 10.4. Screening
  • 10.5. Surgical Assistance

11. AI Medical Imaging Software for Lung Diseases Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Care
  • 11.3. Diagnostic Centers
  • 11.4. Hospitals
  • 11.5. Research Institutes

12. AI Medical Imaging Software for Lung Diseases Market, by Deployment

  • 12.1. Introduction
  • 12.2. Cloud Based
    • 12.2.1. Hybrid Cloud
    • 12.2.2. Private Cloud
    • 12.2.3. Public Cloud
  • 12.3. On Premise
    • 12.3.1. Edge Server
    • 12.3.2. Private Data Center

13. AI Medical Imaging Software for Lung Diseases Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. AI Medical Imaging Software for Lung Diseases Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. AI Medical Imaging Software for Lung Diseases Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Aidoc Ltd.
  • 17.2. Annalise.ai Pty Ltd
  • 17.3. Arterys, Inc.
  • 17.4. GE HealthCare Inc.
  • 17.5. Infervision Technology Co., Ltd.
  • 17.6. Koninklijke Philips N.V.
  • 17.7. Lunit Inc.
  • 17.8. Optellum Ltd.
  • 17.9. Oxipit Labs UAB
  • 17.10. Qure.ai Technologies Pvt. Ltd.
  • 17.11. Riverain Technologies, LLC
  • 17.12. Siemens Healthineers AG
  • 17.13. Thirona NV
  • 17.14. VIDA Diagnostics, Inc.
  • 17.15. Zebra Medical Vision Ltd.

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global AI Medical Imaging Software for Lung Diseases Market, Years Considered for the Study
  • FIGURE 2. Global AI Medical Imaging Software for Lung Diseases Market, Research Design
  • FIGURE 3. Global AI Medical Imaging Software for Lung Diseases Market, Research Framework
  • FIGURE 4. Global AI Medical Imaging Software for Lung Diseases Market, Data Triangulation
  • FIGURE 5. Global AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2025 vs 2032 (%)
  • FIGURE 7. Global AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2025 vs 2032 (%)
  • FIGURE 9. Global AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2025 vs 2032 (%)
  • FIGURE 11. Global AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 13. Global AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2025 vs 2032 (%)
  • FIGURE 17. Global AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global AI Medical Imaging Software for Lung Diseases Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global AI Medical Imaging Software for Lung Diseases Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global AI Medical Imaging Software for Lung Diseases Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global AI Medical Imaging Software for Lung Diseases Market Segmentation & Coverage
  • TABLE 2. Global AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 4. Global Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Managed Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Managed Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Managed Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Professional Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Professional Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Professional Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Software Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Integrated Platform Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Integrated Platform Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Integrated Platform Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Standalone Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Standalone Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Standalone Software Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 23. Global Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Magnetic Resonance Imaging Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Magnetic Resonance Imaging Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Magnetic Resonance Imaging Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Positron Emission Tomography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Positron Emission Tomography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Positron Emission Tomography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global X Ray Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global X Ray Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global X Ray Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 36. Global Chronic Obstructive Pulmonary Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Chronic Obstructive Pulmonary Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Chronic Obstructive Pulmonary Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Pneumonia Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Pneumonia Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Pneumonia Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Tuberculosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Tuberculosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Tuberculosis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 49. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Monitoring Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Monitoring Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Monitoring Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Surgical Assistance Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Surgical Assistance Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Surgical Assistance Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 62. Global Ambulatory Care Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Ambulatory Care Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Ambulatory Care Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 73. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 74. Global AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 75. Global Cloud Based Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Cloud Based Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Cloud Based Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Hybrid Cloud Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Global Hybrid Cloud Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 80. Global Hybrid Cloud Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 81. Global Private Cloud Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Global Private Cloud Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. Global Private Cloud Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 84. Global Public Cloud Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Global Public Cloud Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 86. Global Public Cloud Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 87. Global On Premise Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 88. Global On Premise Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 89. Global On Premise Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 90. Global Edge Server Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 91. Global Edge Server Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 92. Global Edge Server Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 93. Global Private Data Center Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. Global Private Data Center Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 95. Global Private Data Center Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 96. Global AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 97. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 99. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 100. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 101. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 102. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 103. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 104. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 105. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 106. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 107. Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 108. North America AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. North America AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 110. North America AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 111. North America AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 112. North America AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 113. North America AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 114. North America AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 115. North America AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 116. North America AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 117. North America AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 118. North America AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 119. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 120. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 121. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 122. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 123. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 124. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 125. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 126. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 127. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 128. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 129. Latin America AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 130. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 131. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 132. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 133. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 134. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 135. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 136. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 137. Europe AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 138. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 139. Europe AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 140. Europe AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 141. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 142. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 143. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 144. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 145. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 146. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 147. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 148. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 149. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 150. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 151. Middle East AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 152. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 153. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 154. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 155. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 156. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 157. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 158. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 159. Africa AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 160. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 161. Africa AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 162. Africa AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 163. Global AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 164. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 165. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 166. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 167. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 168. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 169. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 170. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 171. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 172. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 173. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 174. ASEAN AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 175. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 176. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 177. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 178. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 179. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 180. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 181. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 182. GCC AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 183. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 184. GCC AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 185. GCC AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 186. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 187. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 188. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 189. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 190. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 191. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 192. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 193. European Union AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 194. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 195. European Union AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 196. European Union AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 197. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 198. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 199. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 200. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 201. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 202. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 203. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 204. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 205. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 206. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 207. BRICS AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 208. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 209. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 210. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 211. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 212. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 213. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 214. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 215. G7 AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 216. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 217. G7 AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 218. G7 AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 219. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 220. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 221. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 222. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 223. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 224. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 225. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 226. NATO AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 227. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 228. NATO AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 229. NATO AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 230. Global AI Medical Imaging Software for Lung Diseases Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 231. United States AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
  • TABLE 232. United States AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 233. United States AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 234. United States AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 235. United States AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 236. United States AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 237. United States AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 238. United States AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 239. United States AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 240. United States AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 241. United States AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 242. Canada AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
  • TABLE 243. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 244. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 245. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 246. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 247. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 248. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 249. Canada AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 250. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 251. Canada AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 252. Canada AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 253. Mexico AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
  • TABLE 254. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 255. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 256. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 257. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 258. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 259. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 260. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 261. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 262. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 263. Mexico AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 264. Brazil AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
  • TABLE 265. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 266. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 267. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 268. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 269. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 270. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 271. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 272. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 273. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 274. Brazil AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 275. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
  • TABLE 276. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 277. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 278. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 279. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 280. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 281. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 282. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 283. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 284. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 285. United Kingdom AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 286. Germany AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
  • TABLE 287. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 288. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 289. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 290. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 291. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 292. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 293. Germany AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 294. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 295. Germany AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 296. Germany AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 297. France AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)
  • TABLE 298. France AI Medical Imaging Software for Lung Diseases Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 299. France AI Medical Imaging Software for Lung Diseases Market Size, by Services, 2017-2032 (USD Million)
  • TABLE 300. France AI Medical Imaging Software for Lung Diseases Market Size, by Software, 2017-2032 (USD Million)
  • TABLE 301. France AI Medical Imaging Software for Lung Diseases Market Size, by Modality, 2017-2032 (USD Million)
  • TABLE 302. France AI Medical Imaging Software for Lung Diseases Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 303. France AI Medical Imaging Software for Lung Diseases Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 304. France AI Medical Imaging Software for Lung Diseases Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 305. France AI Medical Imaging Software for Lung Diseases Market Size, by Deployment, 2017-2032 (USD Million)
  • TABLE 306. France AI Medical Imaging Software for Lung Diseases Market Size, by Cloud Based, 2017-2032 (USD Million)
  • TABLE 307. France AI Medical Imaging Software for Lung Diseases Market Size, by On Premise, 2017-2032 (USD Million)
  • TABLE 308. Russia AI Medical Imaging Software for Lung Diseases Market Size, 2017-2032 (USD Million)

T